Study Protocol Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial

in English. 29 Liu JX, Shi ZM, Li HG, Xu ZY, Zhu YW, Zhao LH, Gao H,Liu LS, Zhu HR, Zhang H. Study of Yifei Kangliu decoctionfor 271 non-small cell lung cancer patients. Yi Xue Yan JiuTong Xun. 2003; 32(3): 23-24. Chinese.30 Guo H, Liu JX, Xu L, Madebo T, Baak JP. Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapy. Integr Cancer Ther. 2011; 10(2): 127-137. 31 You J, Shan MJ, Zhao H. Clinical study of integrative treatment for ninety-one elderly patients with advanced non-small cell lung cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012; 32(6): 774-778. Chinese with abstract in English. 32 Liu LS, Jiang Y, Shen LP, Han ZF, Fan YL, Li HG. Survival analysis of elderly patients with advanced non-small cell lung cancer received traditional Chinese medicine intervention. Shanghai Zhong Yi Yao Da Xue Xue Bao. 2011; 25(6): 774778. Chinese with abstract in English. 33 Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG; Consolidated Standards of Reporting Trials Group. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;